Junfeng Wang

Junfeng Wang

Auto-generated profile, based on publicly available information

Junfeng Wang

Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin’s Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, China

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 August 2021 in JCI Insight
Verified
Journal Article
Open access
PDF file
YZYang Zhan
Yang Zhan
LZLei Zheng
Lei Zheng
JLJia Liu
Jia Liu
DHDongzhi Hu
Dongzhi Hu
JWJunfeng Wang
Junfeng Wang
DKDalu Kong
Dalu Kong
The γδ T cell is a promising candidate cell in tumor immunotherapy. However, γδ T cells polarize to CD39 + γδ Tregs upon colorectal cancer (CRC) induction, and the underlying mechanism remains unclear. Here, we show that the frequency of CD39 + γδ Tregs, which positively correlated with poor prognosis, was significantly higher in right-sided CRC (RSCRC) than in the left-sided CRC (LSCRC). Interestingly, CD39 + γδ Tregs from RSCRC showed stronger immunosuppressive phenotype and function than LSCRC. Furthermore, the quantitative mass spectrometry data show that CD39 + γδ Treg polarization was related to the abnormal activation of the Phospholipase a2-IVa/Arachidonic acid (PLA2G4A/AA) metabolic pathway in RSCRC. Using an in vitro coculture system and an orthotopic murine model of CRC, we show that the overexpression of Pla2g4a in CT26 cells induced CD39 + γδ Tregs, inhibiting the antitumor immune response. Finally, we found that the overall survival of the PLA2G4A hi group was significantly shortened compared with PLA2G4A lo RSCRC, while the survival of LSCRC showed the opposite. Collectively, RSCRC with abnormal PLA2G4A expression educates γδ T cells into CD39 + γδ Tregs to promote tumor progression and metastasis. Our work highlights the interaction between cancer cells and immune cells by distinguishing the primary tumor site and deepens the understanding of the tumor microenvironment and immunosuppression.